Search filters

List of works by Johan Gobom

A novel quantification-driven proteomic strategy identifies an endogenous peptide of pleiotrophin as a new biomarker of Alzheimer's disease

scientific article published on 17 October 2017

A selected reaction monitoring (SRM)-based method for absolute quantification of Aβ38, Aβ40, and Aβ42 in cerebrospinal fluid of Alzheimer's disease patients and healthy controls.

scientific article published in January 2013

APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease

scientific article published on 27 May 2020

An integrated workflow for multiplex CSF proteomics and peptidomics-identification of candidate cerebrospinal fluid biomarkers of Alzheimer's disease

scientific article published on 22 December 2014

Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's disease

scientific article published on 03 November 2020

Characterization of tau in cerebrospinal fluid using mass spectrometry.

scientific article published on 20 March 2008

Establishment of reference values for plasma neurofilament light based on healthy individuals aged 5-90 years

scientific article published in 2022

Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease.

scientific article published on 25 September 2010

P3-071: Mass spectrometric characterization of tau in cerebrospinal fluid

Reference measurement procedure for CSF amyloid beta (Aβ)1-42 and the CSF Aβ1-42 /Aβ1-40 ratio - a cross-validation study against amyloid PET.

scientific article published on 31 August 2016

Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.

scientific article published on August 2012